Otsuka Crohn’s treatment
This article was originally published in The Gray Sheet
Executive Summary
Adacolumn apheresis system's 230-patient, 40-center trial will determine safety and effectiveness of Crohn's disease treatment, following IDE sign-off from FDA. The system works by drawing blood from the patient's body, removing active white blood cells that are causing infection, and returning the remaining blood to the patient, the Rockville, Md. firm explains...